# The Effect of Z-338 in Subjects With Functional Dyspepsia

> **NCT00458328** · PHASE2 · COMPLETED · sponsor: **Zeria Pharmaceutical** · enrollment: 40 (estimated)

## Conditions studied

- Functioanl Dyspepsia

## Interventions

- **DRUG:** Z-338

## Key facts

- **NCT ID:** NCT00458328
- **Lead sponsor:** Zeria Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-09
- **Final completion:** 2010-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00458328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00458328, "The Effect of Z-338 in Subjects With Functional Dyspepsia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00458328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*